Envista Holdings Corporation (NVST)

NYSE · Medical Instruments & Supplies

23.51
-1.10 (-4.47%)
Updated Nov 2, 3:05 AM ET
AI Rating
Hold
Overall Score
46
Trend
3
Momentum
67
Risk
85

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 20, 2025 260 sessions Oct 30, 2026

AI Analysis

Envista Holdings Corporation is trading at $23.51, down 4.47% on the session. The 50 day average sits at $24.60 and the 200 day at $25.74, which puts the stock in a downtrend. RSI is at 47.7, which reads as neutral, and MACD is bullish crossover. Volume is above average.

The nearest support is around $23.11 with resistance near $23.67, so that band frames the current range. Average daily movement is roughly $0.70, or about 3.0% of the share price, which is what any stop placement has to allow for. The overall health score of 46 out of 100 combines a trend score of 3, momentum of 67 and a risk score of 85.

Technical indicators

RSI (14)
47.7
neutral
MACD
-0.115
bullish crossover
SMA 20
23.28
SMA 50
24.60
SMA 200
25.74
downtrend
ATR (14)
0.70
avg daily range
Support
23.11
Resistance
23.67
Volume vs 20d
1.32x
above average
Volatility
30.8%
annualised
1 month
+1.51%
3 months
-14.10%

About Envista Holdings Corporation

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.